Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nephro Care IndiaNSE:NEPHROCARE +2.29%48 PB Ratio is 2.70 as of Sep. 22, 2026, which is 39% below its 10-year median of 4.40. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review. Among 614 Healthcare Providers & Services companies, Nephro Care India ranks worse than 64.5% on this metric.
The historical rank and industry rank for Nephro Care India's PB Ratio or its related term are showing as below:
NSE:NEPHROCARE'
s PB Ratio Range Over the Past 10 Years
Min: 1.69 Med: 4.4 Max: 34.73
Current: 2.71
During the past 6 years, Nephro Care India's highest PB Ratio was 34.73. The lowest was 1.69. And the median was 4.40.
NSE:NEPHROCARE's PB Ratio is ranked worse than 64.5% of 614
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs NSE:NEPHROCARE: 2.71
During the past 12 months, Nephro Care India's average Book Value Per Share Growth Rate was 6.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 185.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 411.30% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Nephro Care India was 904.20% per year. The lowest was 185.50% per year. And the median was 376.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nephro Care India PB Ratio Related Terms
Nephro Care India PB Ratio Historical Data
* Premium members only.
The historical data trend for Nephro Care India's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEPHROCARE vs HCA, THC, EHC: PB Ratio Comparison
For the Medical Care Facilities subindustry, Nephro Care India's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nephro Care India's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nephro Care India (NSE:NEPHROCARE) has a PB Ratio of 2.70 as of Sep. 22, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nephro Care India and its competitors. This is 39% below median its historical median of 4.40. Over the past decade, Nephro Care India's PB Ratio has ranged from 1.69 to 34.73. According to the industry distribution chart, Nephro Care India ranks #396 out of 614 companies in the Healthcare Providers & Services industry, placing it in the top 64.5%.
Is Nephro Care India's PB Ratio too high?
Nephro Care India's current PB Ratio of 2.70 is 39% below median its 10-year median of 4.40. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 34.73. The Healthcare Providers & Services industry median PB Ratio is 1.88. Nephro Care India's value of 2.70 is 43.6% above this industry median. Based on the distribution chart, Nephro Care India ranks #396 out of 614 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nephro Care India ranks #396 out of 614 companies for PB Ratio. This places Nephro Care India in the lower half of its industry. The industry median PB Ratio is 1.88. Nephro Care India's value of 2.70 is 43.6% above this benchmark. Historically, Nephro Care India's own PB Ratio has ranged from 1.69 to 34.73 over the past decade. While the company's 10-year median is 4.40 vs. the industry median of 1.88, Nephro Care India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.88, based on 614 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current PB Ratio of 2.70 is 43.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nephro Care India and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current PB Ratio is 2.70, which is 39% below median its own 10-year median of 4.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current PB Ratio of 2.70. The current PB Ratio is 2.70, which is 39% below median its 10-year median of 4.40 and 43.6% above the Healthcare Providers & Services industry median of 1.88. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current PB Ratio is 2.70 as of Sep. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
